For research use only. We do not sell to patients.
Vudalimab
CAS No. : 2329669-72-7
Biological Activity：Vudalimab is a potent dual PD-1 and CTLA-4 inhibitor as a fully humanized bispecific monoclonal antibody. Vudalimab targets immune checkpoint receptors PD-1 and CTLA-4 and promotes tumor-selective T-cell activation.
Research Area：Inflammation/Immunology
Targets：Interleukin Related|PD-1/PD-L1|CTLA-4
Related Small Molecules:AX-024;Ginsenoside F3;Perakizumab;PD-1/PD-L1-IN-15;PNRI-299;PD-1/PD-L1-IN 5 TFA;CTX-471;Ac-YVAD-CHO;Deucravacitinib;PD-1/PD-L1-IN-25;Mulberroside A;NFAT Transcription Factor Regulator-1;IL-17A antagonist 1;Kansuinine B;Ginsenoside Rc;PD-1/PD-L1-IN-18;5(S)15(S)-DiHETE;IL-17A inhibitor 2;PD-1/PD-L1-IN-22;Anti-Mouse IL-1b Antibody;Raleukin;Ossirene;Toripalimab;VGX-1027;PD-1/PD-L1-IN-23;RCGD423;Clazakizumab
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
